Although serum levels of IL-33 and ST2 were up-regulated in liver failure and CHB, the relevance of serum levels of both molecules and patients with hepatitis B virus infection needed further research and serum alanine aminotransferase (ALT) activity is an important marker for liver damage in patients with CHB. The gene discussed is IL33; the disease is Hepatic failure.